Acadia Healthcare (NASDAQ:ACHC) Sets New 1-Year High After Analyst Upgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price hit a new 52-week high during mid-day trading on Wednesday after TD Cowen raised their price target on the stock from $30.00 to $36.00. TD Cowen currently has a buy rating on the stock. Acadia Healthcare traded as high as $32.93 and last traded at $32.86, with a volume of 727492 shares. The stock had previously closed at $31.60.

ACHC has been the subject of several other research reports. Guggenheim boosted their price objective on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a report on Monday, May 4th. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. Royal Bank Of Canada boosted their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. UBS Group raised their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 9th. Finally, Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective for the company in a report on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $28.69.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Aberdeen Group plc boosted its holdings in shares of Acadia Healthcare by 72.3% in the 4th quarter. Aberdeen Group plc now owns 743,925 shares of the company’s stock worth $10,556,000 after buying an additional 312,172 shares during the last quarter. Louisiana State Employees Retirement System purchased a new stake in Acadia Healthcare during the first quarter worth about $957,000. SG Americas Securities LLC raised its position in Acadia Healthcare by 717.8% in the fourth quarter. SG Americas Securities LLC now owns 292,425 shares of the company’s stock worth $4,150,000 after acquiring an additional 256,669 shares during the period. Prescott Group Capital Management L.L.C. bought a new stake in Acadia Healthcare in the fourth quarter worth about $2,838,000. Finally, FourThought Financial Partners LLC purchased a new position in Acadia Healthcare in the fourth quarter valued at about $325,000.

Acadia Healthcare Stock Up 4.6%

The stock’s 50-day moving average price is $26.28 and its two-hundred day moving average price is $22.12. The stock has a market capitalization of $3.04 billion, a P/E ratio of -2.70, a P/E/G ratio of 10.19 and a beta of 0.64. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. During the same quarter in the previous year, the firm posted $0.40 EPS. Acadia Healthcare’s revenue was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, research analysts expect that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.